Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 544

1.

DNA methylation profile in diffuse type gastric cancer: evidence for hypermethylation of the BRCA1 promoter region in early-onset gastric carcinogenesis.

Bernal C, Vargas M, Ossandón F, Santibáñez E, Urrutia J, Luengo V, Zavala LF, Backhouse C, Palma M, Argandoña J, Aguayo F, Corvalán A.

Biol Res. 2008;41(3):303-15. doi: /S0716-97602008000300007. Epub 2009 Apr 23.

2.

[Hierarchical clustering analysis to detect associations between clinical and pathological features of gastric tumors and hypermethylation of suppressor genes].

Zavala G L, Luengo J V, Ossandón C F, Riquelme S E, Backhouse E C, Palma V M, Argandoña C J, Cumsille MA, Corvalán R A.

Rev Med Chil. 2007 Jan;135(1):17-25. Epub 2007 Mar 6. Spanish.

3.

Promoter hypermethylation of multiple genes in early gastric adenocarcinoma and precancerous lesions.

Zou XP, Zhang B, Zhang XQ, Chen M, Cao J, Liu WJ.

Hum Pathol. 2009 Nov;40(11):1534-42. doi: 10.1016/j.humpath.2009.01.029. Epub 2009 Aug 19.

PMID:
19695681
4.

CpG island methylation status in gastric carcinoma with and without infection of Epstein-Barr virus.

Chang MS, Uozaki H, Chong JM, Ushiku T, Sakuma K, Ishikawa S, Hino R, Barua RR, Iwasaki Y, Arai K, Fujii H, Nagai H, Fukayama M.

Clin Cancer Res. 2006 May 15;12(10):2995-3002.

5.

Profile of aberrant CpG island methylation along multistep gastric carcinogenesis.

Kang GH, Lee S, Kim JS, Jung HY.

Lab Invest. 2003 Apr;83(4):519-26. Erratum in: Lab Invest. 2003 Jul;83(7):1093.

PMID:
12695555
6.

Reprimo as a potential biomarker for early detection in gastric cancer.

Bernal C, Aguayo F, Villarroel C, Vargas M, Díaz I, Ossandon FJ, Santibáñez E, Palma M, Aravena E, Barrientos C, Corvalan AH.

Clin Cancer Res. 2008 Oct 1;14(19):6264-9. doi: 10.1158/1078-0432.CCR-07-4522.

7.

Distinct promoter hypermethylation of p16INK4a, CDH1, and RAR-beta in intestinal, diffuse-adherent, and diffuse-scattered type gastric carcinomas.

Oue N, Motoshita J, Yokozaki H, Hayashi K, Tahara E, Taniyama K, Matsusaki K, Yasui W.

J Pathol. 2002 Sep;198(1):55-9.

PMID:
12210063
8.

DNA methylation of multiple genes in gastric carcinoma: association with histological type and CpG island methylator phenotype.

Oue N, Oshimo Y, Nakayama H, Ito R, Yoshida K, Matsusaki K, Yasui W.

Cancer Sci. 2003 Oct;94(10):901-5.

9.
10.

Risk prediction of gastric cancer by analysis of aberrant DNA methylation in non-neoplastic gastric epithelium.

Tahara T, Arisawa T, Shibata T, Wang FY, Nakamura M, Sakata M, Nagasaka M, Takagi T, Kamiya Y, Fujita H, Nakamura M, Hasegawa S, Iwata M, Takahama K, Watanabe M, Hirata I, Nakano H.

Digestion. 2007;75(1):54-61. Epub 2007 Apr 16.

PMID:
17438355
11.

CpG island methylation in premalignant stages of gastric carcinoma.

Kang GH, Shim YH, Jung HY, Kim WH, Ro JY, Rhyu MG.

Cancer Res. 2001 Apr 1;61(7):2847-51.

12.

[CpG island methylation of E-cadherin gene promoter in gastric carcinoma].

Zhou YN, Xu CP, Han B, Ji R.

Ai Zheng. 2005 Oct;24(10):1220-4. Chinese.

PMID:
16219136
13.

Promoter methylation status of the DNA repair genes hMLH1 and MGMT in gastric carcinoma and metaplastic mucosa.

Oue N, Sentani K, Yokozaki H, Kitadai Y, Ito R, Yasui W.

Pathobiology. 2001;69(3):143-9.

PMID:
11872960
14.

Combined analysis of E-cadherin gene (CDH1) promoter hypermethylation and E-cadherin protein expression in patients with gastric cancer: implications for treatment with demethylating drugs.

Graziano F, Arduini F, Ruzzo A, Mandolesi A, Bearzi I, Silva R, Muretto P, Testa E, Mari D, Magnani M, Scartozzi M, Cascinu S.

Ann Oncol. 2004 Mar;15(3):489-92.

15.

[Frequent promoter hypermethylation of several tumor suppressor genes in gastric carcinoma and foveolar epithelium].

Cai JC, Liu D, Zhang HP, Zhong S, Xia NS.

Zhonghua Zhong Liu Za Zhi. 2007 Jul;29(7):510-3. Chinese.

PMID:
18069630
16.

Genetic, epigenetic, and clinicopathologic features of gastric carcinomas with the CpG island methylator phenotype and an association with Epstein-Barr virus.

Kusano M, Toyota M, Suzuki H, Akino K, Aoki F, Fujita M, Hosokawa M, Shinomura Y, Imai K, Tokino T.

Cancer. 2006 Apr 1;106(7):1467-79.

17.

E-Cadherin gene promoter hypermethylation in primary human gastric carcinomas.

Tamura G, Yin J, Wang S, Fleisher AS, Zou T, Abraham JM, Kong D, Smolinski KN, Wilson KT, James SP, Silverberg SG, Nishizuka S, Terashima M, Motoyama T, Meltzer SJ.

J Natl Cancer Inst. 2000 Apr 5;92(7):569-73.

18.

[Studies of promoter methylation status and protein expression of E-cadherin gene in associated progression stages of gastric cancer].

Zheng ZH, Sun XJ, Ma MC, Hao DM, Liu YH, Sun KL.

Yi Chuan Xue Bao. 2003 Feb;30(2):103-8. Chinese.

PMID:
12776596
19.

Frequent CpG island methylation in precursor lesions and early gastric adenocarcinomas.

Lee JH, Park SJ, Abraham SC, Seo JS, Nam JH, Choi C, Juhng SW, Rashid A, Hamilton SR, Wu TT.

Oncogene. 2004 Jun 3;23(26):4646-54.

PMID:
15064707
20.

Methylation status of ANAPC1, CDKN2A and TP53 promoter genes in individuals with gastric cancer.

Lima EM, Leal MF, Burbano RR, Khayat AS, Assumpção PP, Bello MJ, Rey JA, Smith MA, Casartelli C.

Braz J Med Biol Res. 2008 Jun;41(6):539-43.

Items per page

Supplemental Content

Write to the Help Desk